We’re delighted to be hosting the ever popular OBN BioTuesday event, taking place on Tuesday 14 May 2024, 18:00 – 21:30 in the Innovation Quarter at Oxford Technology Park.
The theme for the evening is: ‘The Latest R&D in Cell & Gene Therapy’.
Throughout the event, we will hear keynotes from companies leading the way in Cell & Gene Therapy research, followed by a series of presentations from UK R&D SME’s at the forefront of this rapidly growing space, developing promising therapies that mark a radical shift away from traditional treatment modalities, treating the cause of disease, rather than just the symptoms.
Programme:
- 18.00 – 18.30 Guest arrivals and networking
- 18.30 – 19.00 Welcome & Company presentations:
- Helen Tayton-Martin, Chief Business & Strategy Officer and Co-Founder of Adaptimmune
- Lonza (Speaker TBA)
- Kevin Takuya Vela, Collaborations Manager at the Cell & Gene Therapy Catapult
- Lara Campana, VP Research Operations and Co-Founder of Resolution Therapeutics
- Felix Dobbs, Co-Founder & CEO of Broken String Biosciences
- 20.00 – 20.30 Audience & Presenter Q&A
- 20.30 – 21.30 Networking
For more information and to register to attend, visit: Online booking form.
